REGULATION AND DRG EFFECTS ON HOSPITAL MORTALITY RATES

监管和 DRG 对医院死亡率的影响

• 批准号: 3371763
• 负责人: LARRY M MANHEIM
• 金额: $ 29.4万
• 依托单位: NORTHWESTERN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-04-01 至 1990-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3371763
• 关键词: health care cost /financing; health care quality; health care service evaluation; hospital analysis; hospital utilization; human mortality; medical indigency

This research will examine the extent to which hospital outcomes, as measured by hospital mortality and readmission rates, are related to the market and regulatory environment faced by the hospital. It will also explore the role of organizational strategy in determining the effects of market and regulatory factors on hospital outcomes. A database for 550 system and 900 competitor hospitals in market areas covering 45 states across the country has been assembled. For these hospitals data on costs, resources, competition, DRG indexes, hospital strategies and hospital outcomes have been collected for 1983-84 and, for some variables, updated to 1986. Mortality and readmission data will be collected for 1987-88 and where necessary other data will be updated. A model of the effects of DRGs, market price competition and hospital strategies on patient outcomes will be specified and tested using these data. The analysis will provide valuable information on the role of market and strategy factors in the behavior of hospitals and the effect of that behavior on hospital outcomes. It will also provide information on trends in adjusted hospital mortality data in the period since the introduction of Medicare prospective payment.

这项研究将检查医院的结果， 以住院死亡率和再入院率衡量， 有关的市场和监管环境所面临的 医院 它还将探讨组织战略的作用 在确定市场和监管因素对 医院的结果。 550家系统医院和市场上900家竞争医院的数据库 全国45个州的地区已经集结完毕。 对于这些医院的成本、资源、竞争、DRG数据 指标、医院策略和医院结果， 1983 - 84年收集的数据，某些变量的数据更新至1986年。 将收集1987 - 88年的死亡率和再入院数据， 如有需要，其他数据将予更新。 影响的模型 DRGs、市场价格竞争与医院策略 将使用这些数据指定和测试患者结局。 这项分析将提供关于以下方面作用的宝贵资料： 医院行为中的市场和战略因素， 行为对医院结果的影响。 它还将提供 2000年经调整的医院死亡率数据趋势的资料 自推出医疗保险前瞻性付款以来的一段时间。